Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Apr 22:36:e20240144en.
doi: 10.62675/2965-2774.20240144-en. eCollection 2024.

Efficacy of melatonin in decreasing the incidence of delirium in critically ill adults: a randomized controlled trial

[Article in English, Portuguese]
Anjishnujit Bandyopadhyay  1 , Lakshmi Narayana Yaddanapudi  2 , Vikas Saini  2 , Neeru Sahni  2 , Sandeep Grover  3 , Sunaakshi Puri  2 , Vighnesh Ashok  2
Affiliations
Randomized Controlled Trial

Efficacy of melatonin in decreasing the incidence of delirium in critically ill adults: a randomized controlled trial

[Article in English, Portuguese]
Anjishnujit Bandyopadhyay et al. Crit Care Sci. .

Abstract
in English, Portuguese

Objective: To determine whether enteral melatonin decreases the incidence of delirium in critically ill adults.

Methods: In this randomized controlled trial, adults were admitted to the intensive care unit and received either usual standard care alone (Control Group) or in combination with 3mg of enteral melatonin once a day at 9 PM (Melatonin Group). Concealment of allocation was done by serially numbered opaque sealed envelopes. The intensivist assessing delirium and the investigator performing the data analysis were blinded to the group allocation. The primary outcome was the incidence of delirium within 24 hours of the intensive care unit stay. The secondary outcomes were the incidence of delirium on Days 3 and 7, intensive care unit mortality, length of intensive care unit stay, duration of mechanical ventilation and Glasgow outcome score (at discharge).

Results: We included 108 patients in the final analysis, with 54 patients in each group. At 24 hours of intensive care unit stay, there was no difference in the incidence of delirium between Melatonin and Control Groups (29.6 versus 46.2%; RR = 0.6; 95%CI 0.38 - 1.05; p = 0.11). No secondary outcome showed a statistically significant difference.

Conclusion: Enteral melatonin 3mg is not more effective at decreasing the incidence of delirium than standard care is in critically ill adults.

Objetivo:: Determinar se a melatonina enteral diminui a incidência de delirium em adultos em estado grave.

Métodos:: Neste estudo controlado e randomizado, os adultos foram admitidos à unidade de terapia intensiva e/ou receberam apenas o padrão de cuidado habitual (Grupo Controle) ou o tratamento combinado com 3mg de melatonina enteral uma vez ao dia às 21h (Grupo Melatonina). A ocultação da alocação foi feita por meio de envelopes selados opacos e numerados sequencialmente. O intensivista que avaliou o delirium e o pesquisador que realizou a análise dos dados foram cegados quanto à alocação do grupo. O desfecho primário foi a incidência de delirium dentro de 24 horas de internação na unidade de terapia intensiva. Os desfechos secundários foram a incidência de delirium nos dias 3 e 7, a mortalidade na unidade de terapia intensiva, a duração da internação na unidade de terapia intensiva, a duração da ventilação mecânica e o escore da escala de desfecho de Glasgow (na alta).

Resultados:: Foram incluídos 108 pacientes na análise final, com 54 sujeitos em cada grupo. Em 24 horas de internação na unidade de terapia intensiva, a incidência de delirium não foi diferente entre os Grupos Melatonina e Controle (29,6% versus 46,2%; RR = 0,6; IC95% 0,38 - 1,05; p = 0,11). Nenhum desfecho secundário apresentou diferenças estatisticamente significativas.

Conclusão:: Em adultos em estado grave, 3mg de melatonina enteral não foi mais eficaz que os cuidados padrão na redução da incidência de delirium.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None.

Figures

Figure 1
Figure 1. Consolidated Standards of Reporting Trials flowchart of the study.
Figura 1
Figura 1. Fluxograma do estudo do Consolidated Standards of Reporting Trials.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Vahia VN. Diagnostic and statistical manual of mental disorders 5: a quick glance. Indian J Psychiatry. 2013;55(3):220–223. - PMC - PubMed
    1. Ouimet S, Kavanagh BP, Gottfried SB, Skrobik Y. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med. 2007;33(1):66–73. - PubMed
    1. Malik AK, Baidya DK, Anand RK, Subramaniam R. A new ICU delirium prevention bundle to reduce the incidence of delirium: a randomized parallel group trial. Indian J Crit Care Med. 2021;25(7):754–760. - PMC - PubMed
    1. Tilouche N, Hassen MF, Ali HB, Jaoued O, Gharbi R, El Atrous SS. Delirium in the intensive care unit: incidence, risk factors, and impact on outcome. Indian J Crit Care Med. 2018;22(3):144–149. - PMC - PubMed
    1. Delaney LJ, Van Haren F, Lopez V. Sleeping on a problem: the impact of sleep disturbance on intensive care patients - a clinical review. Ann Intensive Care. 2015;5:3–3. - PMC - PubMed

Publication types